Guangzhou Jet Bio-Filtration Co., Ltd. (SHA:688026)
15.08
-0.05 (-0.33%)
Jun 20, 2025, 3:00 PM CST
SHA:688026 Revenue
Guangzhou Jet Bio-Filtration had revenue of 123.82M CNY in the quarter ending March 31, 2025, with 26.00% growth. This brings the company's revenue in the last twelve months to 584.20M, up 19.94% year-over-year. In the year 2024, Guangzhou Jet Bio-Filtration had annual revenue of 558.66M with 20.63% growth.
Revenue (ttm)
584.20M
Revenue Growth
+19.94%
P/S Ratio
3.56
Revenue / Employee
539.93K
Employees
1,082
Market Cap
2.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 558.66M | 95.56M | 20.63% |
Dec 31, 2023 | 463.10M | -146.73M | -24.06% |
Dec 31, 2022 | 609.82M | -245.83M | -28.73% |
Dec 31, 2021 | 855.66M | 351.72M | 69.80% |
Dec 31, 2020 | 503.93M | 256.44M | 103.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |